scholarly journals Nuclear   catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong

2003 ◽  
Vol 56 (6) ◽  
pp. 347-352 ◽  
Author(s):  
S C C Wong
Keyword(s):  
Colorectal Cancer ◽  
Hong Kong ◽  
Diagnostic Marker

The real-world use of regorafenib for metastatic colorectal cancer: multicentre analysis of treatment pattern and outcomes in Hong Kong

2016 ◽  
Vol 93 (1101) ◽  
pp. 395-400 ◽  
Author(s):  
Ka-On Lam ◽  
Kin-Chung Lee ◽  
Joanne Chiu ◽  
Victor Ho-Fun Lee ◽  
Roland Leung ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Hong Kong ◽  
Metastatic Colorectal Cancer ◽  
Real World ◽  
Treatment Pattern ◽  
The Real

scholarly journals P-270 Regorafenib for metastatic colorectal cancer in community setting: a multicenter retrospective analysis in Hong Kong

2015 ◽  
Vol 26 ◽  
pp. iv79 ◽  
Author(s):  
K.O. Lam ◽  
K.C. Lee ◽  
V.H.F. Lee ◽  
H.C.K. Sze ◽  
J.W.Y. Chiu ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Hong Kong ◽  
Metastatic Colorectal Cancer ◽  
Retrospective Analysis ◽  
Community Setting

scholarly journals Identification of MicroRNA 15b-3p as a Diagnostic Marker for Early Stage of Colorectal Cancer Through Comprehensive RNA Analysis

2021 ◽  
Author(s):  
RYOICHI TSUKAMOTO ◽  
MASAKI HOSOYA ◽  
MIDORI FUKAYA ◽  
NORIHIKO YOKOYAMA ◽  
SHINGO KAWANO ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Diagnostic Marker ◽  
Early Stage ◽  
Rna Analysis

scholarly journals The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in colorectal cancer patients: study protocol for a pilot single-blinded, randomized sham-controlled trial

2019 ◽  
Author(s):  
Kaiyin Chan ◽  
Louisa Lui ◽  
Kaling Yu ◽  
Kwongwai Lau ◽  
Manchi Lai ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Hong Kong ◽  
Peripheral Neuropathy ◽  
Chinese Medicine ◽  
Cancer Patients ◽  
Controlled Trial ◽  
Sham Acupuncture ◽  
Acupuncture Group ◽  
Efficacy And Safety ◽  
Colorectal Cancer Patients

Abstract Background: Colorectal cancer is the most common cancer in Hong Kong. Oxaliplatin-based chemotherapy is a major first-line conventional therapy for advanced and metastatic colorectal cancer. However, oxaliplatin causes chemotherapy-induced peripheral neuropathy (CIPN). Acupuncture has long been used to alleviate limb numbness in Chinese Medicine Practice. This pilot study aims to examine the efficacy and safety of acupuncture for alleviating CIPN in colorectal cancer patients in Hong Kong. Methods/Design: This is a pilot single-blinded, randomized, sham-controlled trial. Eighty-four eligible patients, who are Hong Kong Chinese aged ≥18 years diagnosed with colorectal cancer and undergoing oxaliplatin-based chemotherapy, will be randomized in a ratio of 1:1 to electro-acupuncture group and sham-controlled group. During a 12-week treatment period, patients in electro-acupuncture group will undergo electro-acupuncture once a week from the first cycle of chemotherapy, patients in control group will receive sham-acupuncture, and the patients in both groups will be followed up for twelve weeks. The primary outcome measure is the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOC-Ntx) questionnaire. The secondary outcome measures include numerical rating scale (NRS) for numbness/pain, vibration and light touch sense test, quality of life questionnaire-C30 of European Organization for Research and Treatment of Cancer (EORTC QLQ-C30) and Constitution of Chinese Medicine Questionnaire (CCMQ). Discussion: The study will compare electro-acupuncture with sham acupuncture to explore the feasibility for electro-acupuncture in improving symptoms caused by chemotherapy-induced peripheral neuropathy.

Sign in / Sign up

Export Citation Format

Share Document